The global life sciences and laboratory equipment market revenue was around US$ 48.6 billion in 2022 and is estimated to reach US$ 82.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the forecast period from 2023 to 2031.
Laboratory equipment means systems and tools used for development, research, and analysis in a variety of industries, like proteomics, pharmaceutical and biotechnology, diagnostics, and genomics. It includes several pieces of types of equipment like DNA sequencers, centrifuges, spectrometers, microscopes, PCR machines, and other specialized equipment used in life science laboratories.
Market Driving Factors
Increasing prevalence of infectious diseases. Infectious diseases including Ebola, HIV, tuberculosis, and others are rising rapidly. This element has a significant impact on the market growth. For instance, according to a World Health Organisation report, around 1.4 million people are suffering from tuberculosis, hence the demand for equipment such as spectrophotometers and homogenizers is fast increasing. As a result, it aids to boost the market expansion.
Increasing technological advancements in the field of laboratory equipment, a rise in the number of clinical diagnostic methods, and an increase in public and private healthcare investments all contribute to the market's expansion. Moreover, enhanced diagnostic facilities rising the requirements of laboratory equipment, which propels the Life Sciences & Lab Equipment Market growth.
The high price associated with laboratory equipment impedes market growth.
Regional Analysis
Asia Pacific is estimated to dominate the market during the forecast period. This is due to the increased prevalence of infectious disorders requiring lab testing, favorable reimbursement policies, and high healthcare spending. In addition, the utilization of cutting-edge technologies also aids to boost market expansion.
North America is predicted to dominate the market during the projection period. This expansion is attributed to rising drug development and discovery programs, rising funding from several corporate and public organizations for life sciences research, the presence of several significant suppliers in this region, and increased advancement in healthcare technologies are boosting the market growth.
Segmentation Insights
Technology Insights
The spectroscopy segment is estimated to dominate the market during the forecast period. Several medical and diagnostic applications propel the need for lab tests. Photon time-of-flight spectroscopy can help such treatment approaches by providing information on the optical characteristics of tissue reactions. This technique is quick, non-destructive, and requires little or no preparation before sample collection. The development of chemometrics has enhanced its susceptibility to detecting tiny differences in complex datasets.
End-user Insights
The pharmaceutical and biotechnology segment is estimated to dominate the market during the projection period. Rising demand for innovative pharmaceuticals, as well as the occurrence and spread of many debilitating conditions, are driving market expansion. In addition, the rising unmet needs of many chronic and unusual illnesses around the world have increased the demand for pharmaceutical and biopharmaceutical drugs worldwide.
Prominent Companies
Segmentation Outline
The global life sciences and laboratory equipment market segmentation focuses on Equipment, Technology, Application, End-user, and Region.
By Equipment
By Technology
By Application
By End-user
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET, BY EQUIPMENT
5.1 OVERVIEW
5.2 COLD STORAGE
5.3 LAB OVENS & FURNACES
5.4 LIQUID HANDLING
5.5 LAB CENTRIFUGES & SHAKERS
5.6 MICROBIOLOGICAL INCUBATORS & ENVIRONMENTAL CHAMBERS
5.7 WATER BATHS
5.8 CIRCULATORS & CHILLERS
5.9 ANALYTICAL & MEASURING INSTRUMENTS
6 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 SPECTROSCOPY
6.3 CHROMATOGRAPHY
6.4 PCR
6.5 IMMUNOASSAYS
6.6 LYOPHILIZATION
6.7 CLINICAL CHEMISTRY ANALYZERS
6.8 MICROSCOPY
6.9 FLOW CYTOMETRY
6.10 CENTRIFUGES
6.11 ELECTROPHORESIS
7 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CELL CULTURE & CELL THERAPY
7.3 CANCER RESEARCH
7.4 DRUG DISCOVERY
7.5 GENOMICS
7.6 IN VITRO FERTILIZATION
7.7 BIOPROCESS
7.8 METABOLOMICS
7.9 PROTEOMICS
8 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET, BY END-USER
8.1 OVERVIEW
8.2 CLINICAL AND DIAGNOSTICS
8.3 RESEARCH
8.4 ACADEMIC & GOVERNMENT INSTITUTIONS
8.5 PHARMACEUTICALS & BIOTECHNOLOGY
8.6 BLOOD BANKS
9 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL LIFE SCIENCES AND LABORATORY EQUIPMENT MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 DANAHER CORPORATION
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 AGILENT TECHNOLOGIES INC
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 ILLUMINA INC
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 WATERS CORPORATION
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 BIO-RAD LABORATORIES
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 PERKINELMER INC
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.8. BRUKER CORPORATION
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.9 QIAGEN N.V.
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.10 GE HEALTHCARE LIFE SCIENCES
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.11 BECTON, DICKINSON, AND COMPANY
11.11.1 OVERVIEW
11.11.2 FINANCIAL PERFORMANCE
11.11.3 PRODUCT OUTLOOK
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.12 MERCK KGAA
11.12.1 OVERVIEW
11.12.2 FINANCIAL PERFORMANCE
11.12.3 PRODUCT OUTLOOK
11.12.4 KEY DEVELOPMENTS
11.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.13 SHIMADZU CORPORATION
11.13.1 OVERVIEW
11.13.2 FINANCIAL PERFORMANCE
11.13.3 PRODUCT OUTLOOK
11.13.4 KEY DEVELOPMENTS
11.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.14 SARTORIUS AG
11.14.1 OVERVIEW
11.14.2 FINANCIAL PERFORMANCE
11.14.3 PRODUCT OUTLOOK
11.14.4 KEY DEVELOPMENTS
11.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.15 CHARLES RIVER LABORATORIES INTERNATIONAL INC
11.15.1 OVERVIEW
11.15.2 FINANCIAL PERFORMANCE
11.15.3 PRODUCT OUTLOOK
11.15.4 KEY DEVELOPMENTS
11.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.16 LONZA GROUP AG
11.16.1 OVERVIEW
11.16.2 FINANCIAL PERFORMANCE
11.16.3 PRODUCT OUTLOOK
11.16.4 KEY DEVELOPMENTS
11.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.17 EPPENDORF AG
11.17.1 OVERVIEW
11.17.2 FINANCIAL PERFORMANCE
11.17.3 PRODUCT OUTLOOK
11.17.4 KEY DEVELOPMENTS
11.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.18 OLYMPUS CORPORATION
11.18.1 OVERVIEW
11.18.2 FINANCIAL PERFORMANCE
11.18.3 PRODUCT OUTLOOK
11.18.4 KEY DEVELOPMENTS
11.18.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.19 BIO-TECHNE CORPORATION
11.19.1 OVERVIEW
11.19.2 FINANCIAL PERFORMANCE
11.19.3 PRODUCT OUTLOOK
11.19.4 KEY DEVELOPMENTS
11.19.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.20 F. HOFFMANN-LA ROCHE AG
11.20.1 OVERVIEW
11.20.2 FINANCIAL PERFORMANCE
11.20.3 PRODUCT OUTLOOK
11.20.4 KEY DEVELOPMENTS
11.20.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved